TG Branfalt

Ontario officials will move forward with a plan to let private businesses store and distribute cannabis products — a right currently reserved only for province-run stores.

Medmen Enterprises has announced the cutting of more than 190 jobs; the company says it’s an effort to slim down and focus the cannabis retailer’s national footprint.

Cannabis media company American Marijuana is offering a $36,000 salary for a full-time cannabis reviewer “dream job.”

The district attorney in Brooklyn, New York has announced that charges against the recipient of a large hemp shipment will be dropped; police had confiscated the shipment and described it as a major cannabis bust.

In a landmark occasion for cannabis reform, federal lawmakers in the House Judiciary Committee are expected to vote tomorrow on the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act tomorrow; the bill aims to federally legalize adult-use cannabis.

A new cannabis jobs report suggests that the industry’s U.S. job openings have risen 79 percent from last year with an estimated 211,000 employees now working full-time in the space.

Proposed changes to Thailand’s cannabis laws would allow citizens to cultivate up to six plants and sell their harvests back to the government, who would process it into medical cannabis products.

Former vice president and presidential hopeful Joe Biden said he would not support cannabis legalization without stronger evidence that the plant is not a “gateway drug.”

A former Amazon employee in New Jersey who was fired after failing a drug test for cannabis is suing the online retail giant under a recent state law that prohibits employers from punishing employees for the legal use of medical cannabis.

The Nevada Bar warned in 2017 that attorneys working with cannabis companies could face discipline but, three years later, no disciplinary actions have been taken against lawyers who advise and invest in the cannabis space.

Detroit has joined the 79% of Michigan municipalities to opt-out of the adult-use cannabis industry, in return forfeiting their share of the state’s 10% excise tax imposed on adult-use sales.

The Oregon Court of Appeals this week struck down the state’s recent ban on cannabis vaporizer products.

Democratic presidential candidates Bernie Sanders and Pete Buttigieg each said this week they would support medical cannabis access for veterans if they win the presidency.

A California study is offering $20 gift cards to cannabis consumers in exchange for anonymous information about how much cannabis they use, which will help in determining safe pesticide levels for cannabis crops.

Illinois officials have awarded the state’s first adult-use retailer licenses — 14 dispensaries received “same-site” licenses, meaning they will be allowed to open their existing medical cannabis stores to anyone 21+.

Chicago Mayor Lori Lightfoot proposed major cannabis policy shifts for the city in light of the legalization of adult-use cannabis in Illinois, which is set to take effect January 1.

Cannabis flower prices in Canada have plummeted about 30-40% over the last year of legal sales, according to financial reports from multiple licensed producers.

The Massachusetts Cannabis Control Commission has established a quarantine on all cannabis vaporizers except those designed for patients “to exclusively vaporize marijuana flower.”

Missouri health officials have proposed banning medical cannabis companies from using cash to make state payments, including taxes, fees, and penalties.

The FDA has approved a human trials study by the Yale School of Medicine and CT Pharma investigating the effectiveness of cannabis-based medicines; it’s the first cannabis study on human subjects to be approved by the FDA.

Canadian singer-songwriter Neil Young has encountered hiccups in his application process for U.S. citizenship because of his cannabis use.

Multiple high-profile Rhode Islanders have announced investments into the state’s medical cannabis and industrial hemp industries.

Experts predict that Minnesota could generate up to $300 million in annual tax revenue via by legalizing and regulating adult-use cannabis.

Epidiolex and Sativex, two cannabinoid-based medicines produced by Britain’s GW Pharmaceuticals, have been formally approved for prescription by the National Institute for Health and Care Excellence (NHS).